2023 Volume 40 Issue 3 Pages 192-194
The Japanese Society of Neurological Therapeutics (JSNT) was founded in 1983 as the predecessor of the Society for Neurological Therapy, with the aim of disseminating knowledge of neurological treatment and providing the best treatment available at that time in daily practice. The society has developed with the treatment of neurological diseases, and in recent years with the continuous development of innovative treatments for neurological diseases, the society has been working to promote drug discovery efforts through industry–government–academia exchanges, support for clinical trials, and education for practical clinical research and trials. In order to promote these activities, the Drug Discovery and International Committee and the Drug Discovery Promotion Committee, which is an extension of the International Committee, have been organized to promote drug discovery activities.
Past achievements include the development of guidelines for “standard neurotherapy,” visualization of unmet medical needs through a survey of medical needs in neurological diseases, provision of sessions related to drug discovery at annual meetings, and symposium with the Ministry of Health, Labour and Welfare, the Pharmaceuticals and Medical Devices Agency, the pharmaceutical industry, and others. In addition, the committee has contributed to the promotion of clinical trials in Japan by providing information on clinical trials with the support of academic societies and promoting recruitment through the encouragement of professional networks. Currently, the Drug Discovery Promotion Committee is taking the lead in providing further support by conducting a questionnaire for academic society members to support drug discovery and considering the establishment of a consultation service for academic society members and others. The achievement of JSNT efforts to promote drug discovery to date and the prospects for further activities in the future will be presented.
